Search research articles
Contact Us
Filters
Showing results (71-80 of 182) with videos related to
Page
of 19
Sort By:
Endocrine-Related Cancer
|
January 16, 2013
Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database
Monica Ter-Minassian, Jennifer A Chan, Susanne M Hooshmand, et al.
Cancer Cell
|
March 18, 2022
Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity
Véronique G LeBlanc, Diane L Trinh, Shaghayegh Aslanpour, et al.
Pancreas
|
August 29, 2018
Characterization of the Neuroendocrine Tumor Immune Microenvironment
Annacarolina da Silva, Michaela Bowden, Sui Zhang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 8, 2012
GSK3 temporally regulates neurogenin 2 proneural activity in the neocortex
Saiqun Li, Pierre Mattar, Dawn Zinyk, et al.
The Journal of Biological Chemistry
|
July 23, 2013
Heparan sulfate proteoglycans containing a glypican 5 core and 2-O-sulfo-iduronic acid function as Sonic Hedgehog co-receptors to promote proliferation
Rochelle M Witt, Marie-Lyn Hecht, Maria F Pazyra-Murphy, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 11, 2014
Population based analysis ependymoma patients in Alberta from 1975 to 2007
Gloria B Roldán Urgoiti, Amitabh D Singh, Roger Y Tsang, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Endocrine-Related Cancer
|
January 12, 2026
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)
Jonathan R Strosberg, Tyler Zemla, Susan Geyer, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
August 21, 2023
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
Josefine Kjaer, Thomas E Clancy, Anders Thornell, et al.
Endocrine-Related Cancer
|
June 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Kimberly Perez, Heather Jacene, Jason L Hornick, et al.
Page
of 19
Search research articles
Search
Showing results (71-80 of 182) with videos related to
Sort By:
Page
of 19
Endocrine-Related Cancer
|
January 16, 2013
Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database
Monica Ter-Minassian, Jennifer A Chan, Susanne M Hooshmand, et al.
Cancer Cell
|
March 18, 2022
Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity
Véronique G LeBlanc, Diane L Trinh, Shaghayegh Aslanpour, et al.
Pancreas
|
August 29, 2018
Characterization of the Neuroendocrine Tumor Immune Microenvironment
Annacarolina da Silva, Michaela Bowden, Sui Zhang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 8, 2012
GSK3 temporally regulates neurogenin 2 proneural activity in the neocortex
Saiqun Li, Pierre Mattar, Dawn Zinyk, et al.
The Journal of Biological Chemistry
|
July 23, 2013
Heparan sulfate proteoglycans containing a glypican 5 core and 2-O-sulfo-iduronic acid function as Sonic Hedgehog co-receptors to promote proliferation
Rochelle M Witt, Marie-Lyn Hecht, Maria F Pazyra-Murphy, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 11, 2014
Population based analysis ependymoma patients in Alberta from 1975 to 2007
Gloria B Roldán Urgoiti, Amitabh D Singh, Roger Y Tsang, et al.
Pancreas
|
November 17, 2022
A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors
Kimberly Perez, Matthew H Kulke, Nora K Horick, et al.
Endocrine-Related Cancer
|
January 12, 2026
Cabozantinib for Advanced Grade 3 Neuroendocrine Tumors: Subgroup Analysis of the Phase 3 CABINET Trial (Alliance A021602)
Jonathan R Strosberg, Tyler Zemla, Susan Geyer, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches
|
August 21, 2023
Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study
Josefine Kjaer, Thomas E Clancy, Anders Thornell, et al.
Endocrine-Related Cancer
|
June 22, 2022
SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma
Kimberly Perez, Heather Jacene, Jason L Hornick, et al.
Page
of 19